ASA: Australian Society for Antimicrobials

ASA has made funds available for travel awards for delegates to attend the Society's annual scientific meeting. Awards are made to ASA financial members presenting a proffered paper (oral or poster) at the meeting. Applicants must have current ASA membership and must have been ASA members for at least the last 12 months. The Awards are restricted to ASA members residing in Australia or New Zealand.

ASA members who wish to apply for this award are invited to submit their application to the ASA Secretary Jacqueline Schooneveldt at info@asainc.net.au. The application should include a copy of the abstract and for abstracts with more than one author, a letter stating the relative contribution of the applicant towards the research.

Antimicrobials 2008 ASA Travel Award Recipient
Stamford Plaza Double Bay, Sydney New South Wales
21 - 23 February 2008

Catherine Bennett. University of Melbourne, Australia. More Common than we thought? Methicillin Resistance and PVL in Community-Onset Staphylococcus aureus Infections in Melbourne.

Janet Montgomery. Austin Hospital, Australia. Comparison of Phenotypic Tests for Detection of Plasmid Mediated AmpC-Mediated Beta-lactamases.

Antimicrobials 2007 ASA Travel Award Recipient
Rydges Melbourne, Melbourne Victoria
22 - 24 February 2007

Steven Tong. Royal Darwin Hospital, Australia. Community-Associated Methicillin-
Resistant Staphylococcus aureus: A Prospective Case-Cohort Study in Northern
Australia.

Stephen Tristram. University of Tasmania, Australia. TEM-15 ESBL and Altered PBP3 in Multi-
Resistant Strains of Haemophilus influenzae.

Nicholas Biehl. University of Western Australia, Australia. Community-Onset MRSA Infection:
A Survey of Knowledge and Behaviour of Western Australian General Practitioners.

Antimicrobials 2006 ASA Travel Award Recipient
Crowne Plaza, Coogee Beach, Sydney NSW
23 - 25 February 2006

Kate Dollman. South Australia Department of Health, Australia. National Antimicrobial
Utilisation Surveillance.

Elizabeth Grabsch. Austin Health. Australia. Oxgall Supplement to Mueller-Hinton and Brain-
Heart Infusion Agar Improves the Routine Identification of Low-MIC Vancomycin-Resistant
Enterococci (LM-VRE).

Sreeja Sudhakaran. Monash University. Australia. Inhibition of P-Glycoprotein Mediated
Efflux: A Mechanism to Increase Indinavir Transfer to the Foetus.

Matthew Rawlins, Royal Perth Hospital, Australia. Assessing the Impact of an Antimicrobial
Stewardship Programme Round at a WA Teaching Hospital.

Frances O'Brien. Curtin University. Australia. Plasmid Encoded Fusidic Acid Resistance in Staphylococcus aureus

Tom Solano. Royal Prince Alfred Hospital. Australia. Comparison of Antibiotic Dispensing Data
Versus Administration Data in Intensive Care.

Stephen Tristram. University of Tasmania. Australia. Disc Diffusion Based Screening Tests for
Extended Spectrum Beta Lactamases in Haemophilus influenzae.

Sophia Tan.University of South Australia. Australia Macrolide, lincosamide and streptogramin
resistance in E.faecium

This is awarded to an individual on the basis of a proffered paper (oral or poster) presented during the ASA's Annual Scientific Meeting dealing with the identification of bacterial resistance to antimicrobials in a routine clinical setting.

The applicant must be a financial member of the ASA. The Award is restricted to ASA members residing in Australia or New Zealand. The award committee will take into account the quality and originality of the paper.

The award consists of AU$1000 cash prize, a commemorative plaque, and the provisions of flights, accommodation and registration for the recipient to attend Antimicrobials 2008. The award committee will consist of two ASA committee members and a bioMerieux staff member.

Antimicrobials 2008 bioMerieux ASA Identifying Resistance Travel Award Recipient

Stamford Double Bay, New South Wales

21 - 23 February 2008

Janet Montgomery, Austin Health. Australia.

Comparison of Phenotypic Tests for Detection of Plasmid-Mediated AmpC Beta-lactamases

Antimicrobials 2007 bioMerieux ASA Identifying Resistance Travel Award Recipient
Rydges Melbourne, Melbourne, Victoria

Cheryll McCullough, PathWest Laboratory Medicine WA - Royal Perth Hospital, Australia.
Phenotypic Confirmation of Extended Spectrum B-lactamases in Enterobacteriacae Using
Commercially Prepared Diffusion Systems

Antimicrobials 2006 bioMerieux ASA Identifying Resistance Tracel Award Recipient
Crowne Plaza, Coogee Beach, Sydney NSW
23 - 25 February 2006

Jacqueline Schooneveldt, Queensland Health Pathology Services, Australia.
MRSA Screenung Using the Tube Coagulase on Selective Enrichment Broth and Real Time PCR
Versus Proprietary RT PCR (IDI-MRSA)

Antimicrobials 2005 bioMerieux ASA Identifying Resistance Travel Award Recipient
Cumberland Lorne Resort, Lorne Victoria
24 - 26 February 2005

Routine Tests for Detection of mecA-mediated Resistance in Staphylococcus aureus

Antimicrobials 2004 bioMerieux ASA Identifying Resistance Travel Award Recipient
Novotel Brighton-Le-Sands, Sydney NSW
26 - 28 February 2004

Janet Montgomery. Austin Health. Australia
Accuracy of Routine Detection of Oxacillin Resistance in Clinical Staphylococcus aureus

Antimicrobials 2003 bioMerieux ASA Identifying Resistance Travel Award Recipient
Hilton on the Park, Melbourne VIC

Cheryll McCullough. Royal Perth Hospital, Australia
The Inability of NCCLS Disc Diffusion Oxacillin Interpretive Breakpoint for S aureus to Reliably Detect Oxacillin-Susceptible Staphylococcus lugdunensis

This award is for attendance at the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). The award consists of return economy airfare, accommodation and conference registration up to the value of AU$5,000.

Applicants must have curent ASA membership and must have been an ASA member for at least the last 12 months. The Award is conditional upon the abstract being accepted by the ICAAC program committee for presentation (oral or poster). In addition the recipient of the Award is required to write a report on the meeting for the ASA Newsletter .

The Award will not be made to the same applicant in consecutive years.

ASA members who wish to apply for this award are invited to submit their application to the ASA Secretary Jacqueline Schooneveldt at info@asainc.net.au. The application should include a copy of the ICAAC abstract and for abstracts with more than one author, a letter stating the relative contribution of the applicant towards the research.

ICAAC 2008 AstraZeneca Travel Award Recipient
Washington, USA

Anton Peleg. Beth Israel Deaconess Medical Centre, Boston, USA

Relationship between Virulence and Reduced Susceptibility to Daptomycin in Staphylococcus aureus

Galleria mellonella as a Model System to Study Acinetobacter baumannii Pathogenesis and Therapeutics

Catherine Bennett. The University of Melbourne, Australia

Patient and Infection Characteristics Associated with the Presence of pvl in Community Onset Staphylococcus aureus Infections in Melbourne, Australia

Julie Pearson. PathWest Laboratory Medicine WA - Royal Perth Hospital, Australia

Detection of International Panton-Valentine Leucocidin (PVL) Positive CA-MRSA Clones in Western Australia

ICAAC 2006 AstraZeneca Travel Award Recipient
San Francisco, USA

Ben Howden. Austin Health, Australia
Whole Genome Comparison of a Vancomycin-Susceptible Staphylococcus aureus (VSSA) and a Vancomycin-Intermediate Derivative (VISA) Obtained from a Patient with Vancomycin Treatment Failure

ICAAC 2005 AstraZeneca Travel Award Recipient
Washington DC, USA

Jian Li. Monash University, Australia

In vitro Pharmacodynamics (PD) of Colistin and Colistin Methanesulfonate (CMS) agaianst Acinetobacter baumannii

Ben Howden. Austin Health, Australia
Identification of a New Agar Dilution Screening Method for the Accurate Detection of Heterogenous-Vancomycin Intermediate Staphylococcus aureus (hVISA).

Sue Ballard. Austin Health, Australia
Correlating the Detection of vanB Genes in Faeces to the Presence of Vancomycin Resistant Enterococci (VRE): Interference by vanB containing Anaerobes

Ian Kay. Royal Perth Hospital, Australia
Performance of a Real-time Multiplex PCR Assay versus Culture for the Rapid Detection of vanA and vanB Genes Directly from Clinical Specimens